Transforming the Treatment of Heart Failure

Corvia Atrial Shunt

The Corvia® Atrial Shunt is a novel heart failure (HF) therapy specifically designed to reduce the symptoms associated with high pressures in the heart and lungs. It is the world’s first atrial shunt intended to reduce heart failure hospitalizations and improve quality of life.

Healthcare Professionals

Learn about the Corvia Atrial Shunt, including study results, peer-reviewed publications, and patient identification.

Doctor with stethoscope

Learn about the Corvia Atrial Shunt, including study results, peer-reviewed publications, and patient identification.

Heart Failure

Learn about the different types of heart failure, the symptoms, and the treatment options.

Older couple sitting on couch smiling at each other

Learn about the different types of heart failure, the symptoms, and the treatment options.

Clinical Evidence

Review the clinical evidence for the Corvia Atrial Shunt.

Clinician working on computer in a lab

Review the clinical evidence for the Corvia Atrial Shunt.

500+ Patients

have received the Corvia Atrial Shunt

100+ Hospitals

with Corvia Atrial Shunt experience

17 Countries

in which the Corvia Atrial Shunt has been implanted

7+ Years

post-implant for the first Corvia Atrial Shunt patients

Breakthrough Device Designation

The Corvia Atrial Shunt receives a breakthrough device designation from the FDA.

Corvia Atrial Shunt - Recipient of FDA Breakthough Device Designation

Publications

The Corvia Atrial Shunt is the most clinically studied atrial shunt for the reduction of Left Atrial Pressure (LAP) in HFpEF/HFmrEF patients.